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Legal Regulations on the Advanced Science and
Technology
- Regulations on Life Science -
Summary
Our report centered on legal restrictions on advanced science and technology, especially life
science and technology. The discussion covered several problems that require legal
considerations. The two main themes were the types of possible restrictions and the way to
justify such restrictions. Our discussion can be summarized as follows:
<1> Current status of life sciences and strategy
Life science and technology have been a strategic field of study in many countries and
considered, in particular, as a major source for industrial competitiveness. Perspectives and
policies on reproductive medical technology have been quite different from those on life
science and technology as a whole. While stringent restrictions have been imposed in European
countries, consensus development has been extremely difficult in the U.S., instead leading to
movements toward the promotion, commercialization and further development overseas of
advanced reproductive technology in the private sector. At the same time, in light of growing
efforts for unified regulations in Europe, it is likely that a standard will be formed for life
science and technology used to shed light on reproductive medicine.
<2> Details and History of Regulations in Several Countries
Regulatory laws have been established on reproductive technology in Britain, France and
Germany. Nonetheless, the scope of such regulations varies, although slightly, from country to
country. They differ in such details as the object of restriction. It is thought, however, that the
current regulations are competent enough to handle cloning technology.
<3> Legal views in Japan
The Constitution, civil code, criminal code and medical laws were discussed in connection with
such regulations in Japan.
<4> Limitation on legal restriction
Cloning technology was discussed in relation to academic freedom and other rights. It is
considered that even academic freedom should be subject to a certain degree of restriction and
that, in social application of cloning technology, not only application but also research should
be covered by regulations without exception.
<5> Objects of restriction
When considering regulation of cloning technology, we reviewed every possible aspect of
reproductive technology as a whole, including related technologies that would require
regulation, instead of focusing on cloning technology alone.
<6> Grounds for regulation
[Safety]
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Safety related to cloning technology involves concerns about genetic influences on children and
later generations. Somatic nuclei, in particular, are extremely susceptible to genetic defects and
highly likely to suffer damage during the course of daily life. Humans developed from a
genetically disturbed body nucleus face the possibility of succumbing to adverse effects all over
the body. We have examined several examples of regulations implemented to focus on such
genetic effects (on statistical grounds).
[Social order]
In contrast to conventional reproductive technologies, which had maintained the family
structure from the past, the new cloning technology makes the relationship between the donor
of a body nucleus and the cloned baby highly similar to that between monozygotic twins. It is
the first attempt in history to genetically invent such relationships, which would essentially
disturb social order.
[Conclusions on justifications for regulation]
For the above two reasons, it is acceptable to regulate cloning. In asserting regulation, "human
dignity" as a justification should be paraphrased in more practical terms (e.g., abuse of human
embryo and indivisibility of the human body).
<7> Supplement: Legal responsibilities of researchers
Little discussion has been made in Japan on the responsibilities of researchers in advanced
science and technology. For the application of regulations on advanced technology, we need to
review our problems in a new perspective.
[Weighted liability arising from negligence]
The legal liability of researchers should be examined separately from that of the 'professional
liability' of experts such as physicians and lawyers, because they are quite different in nature.
[General liability arising from negligence]
In general criminal and civil cases, a common interpretation is established concerning
foreseeability and duty to avoid risk. For the introduction of regulations on researchers, it is
essential to form a new standard.
<8> Guidelines by the government and academic societies
As part of regulatory methods, guidelines are considered to have no legal effects. In our
discussion, we have reviewed guidelines on science and technology, especially the ways in
which guidelines should be implemented in an effective manner. Lastly, we examined
technical standards in connection with the scope of judicial review on administrative discretion.
<9> Consensus development effort for regulation
We discussed efforts required to reach a consensus in the public whether regulations should
take the form of laws or guidelines.
[Interested parties required for consensus development]
Interested parties to take the initiative in consensus development effort were categorized into
three groups: (1) directly interested parties, (2) other interested parties and (3) non-interested
professionals. We pointed out the importance of clarifying claims from these parties.
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[Consensus development methodology]
Conventional and new consensus development methods were introduced, including technology
assessment and consensus conferences.
While we were in the process of reviewing our discussion, many new topics have attracted
public attention, including unconfirmed news; the Ishikawa Prefectural Animal Science
Institute and Kinki University jointly succeeded in cloning a cow using body cells (July 5,
1998); an international group composed of scientists from Japan, the U.S., Italy and Britain
cloned at least 50 female mice (July 23); a U.S. scientist declared at a scientific conference that
he would clone himself (September 6, Nikkei); scientists at Tokyo University and the Japan
Science Foundation succeeded in producing organs such as kidneys from an undivided
embryonic cell in a frog and confirming their growth after transplanting them to another frog
(September 13); Wisconsin University successfully isolated ES cells from a human embryo,
and cultured and grew them (November 6); a U.S. investment company and U.S. researchers
announced that they would set up a cloning technology center in Hokkaido (December 1);
HFEA of the British government submitted a report recommending permission to produce
human tissues using cloning technology (December 18); a Korean university transplanted
nuclei from female body cells and eggs and observed division until the egg cells were divided
into quarters (December 15); Wisconsin university at Madison transplanted body cell nuclei
from four different mammals into bovine eggs, divided them and successfully developed them
into embryos (December 28); a private enterprise cloned a cow using a body-cell nucleus
(January 8, 1999); researchers at Tottori university have grown a human spermatogonium in a
mouse (February 2); Italian physicians produced five humans by in-vitro fertilization after
growing human spermatogonia in a mouse (March 17). Under these rapidly changing
circumstances, the establishment of principles regarding life science and technology is strongly
urged in order to prevent social conflicts.
Life science and reproductive technology are being discussed at the Council for Science and
Technology, Science Council and Health Science Council. Discussions will be deepened in the
future for these problems. We hope our report will serve as a material for these discussions.
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